
Public Relations / IR
In today’s capital markets, the role of a director extends well beyond strategic oversight. Public company directors are expected to navigate an intricate landscape of regulatory obligations, investor expectations, and ethical responsibilities. As corporate governance frameworks evolve – driven by the UK Listing Rules (UKLR), the Disclosure Guidance and Transparency Rules (DTR), and the Market Abuse Regulation (MAR) – the standards of director competence and accountability have never been higher.
The Financial Conduct Authority (FCA) and the London Stock Exchange (LSE) continue to reinforce these expectations, ensuring that listed companies maintain systems, controls, and disclosure practices appropriate to their market presence. For directors, this means having not only an awareness of the rules but a practical understanding of how they apply in real time.
At its core, effective director training is about protecting value, for both the company and for its shareholders. It ensures that directors can perform their duties with diligence, integrity, and informed judgement, all while safeguarding the company’s reputation and regulatory standing.
From Governance to Liability: Why Director Training Can’t Be Ignored
Being a public company director carries personal accountability. The UKLR governs disclosure and shareholder approval requirements, while MAR controls how inside information and director dealings are managed.
A simple misstep – even an unintentional one – can lead to serious consequences: suspended trading, FCA investigation, financial penalties, or lasting reputational harm. In some cases, directors themselves can face personal liability or disqualification.
Training helps directors recognise inside information, understand when disclosure can be delayed, and know exactly what their obligations are under MAR and DTR. As the UK regulatory environment grows more complex, the cost of “not knowing” has become prohibitively high.
Making Sense of a Complex Regulatory Landscape
The rulebook for listed companies is intricate and interconnected. Directors need to understand, among other things:
But knowledge alone isn’t enough. Directors must be equipped to interpret and apply them in the context of their company’s operations, transactions, and communications.
What Good Director Training Really Delivers
Embedding Governance into Everyday Decision-Making
Directors who understand their obligations are better equipped to make strategic decisions that align with regulatory standards, market expectations, and corporate purpose.
Training reinforces the importance of involving the Corporate Adviser at the right stages, whether before announcing transactions, issuing financial promotions, or considering capital changes. These practices ensure that governance principles are not an afterthought, but a core part of how the board operates.
Building Transparency and Investor Confidence
Investor confidence is built on transparency and consistency. Boards that demonstrate a command of disclosure rules and governance best practices inspire trust among regulators, investors, and the wider market.
Effective training thus contributes directly to market reputation, reducing the likelihood of regulatory intervention and enhancing the company’s credibility with stakeholders.
Common Compliance Pitfalls
Even experienced directors can misjudge what constitutes a disclosure event or the timing of an announcement. Common issues include:
Any of these can expose the company to regulatory action and market abuse risk.
Why “Not Knowing” Isn’t a Defence
The FCA makes it clear that ignorance of the rules offers no protection. Directors are expected to demonstrate not only that policies exist but that they have been understood and implemented. Robust training, tailored to the board’s specific context, is therefore a critical component of regulatory defence.
When to Seek Expert Guidance
You should consider structured board training if:
The best time to prepare is before a problem arises. Effective training gives directors the tools to act confidently, compliantly, and in the best interests of the company.
How First Sentinel Can Help
At First Sentinel, we work with listed and pre-IPO companies to design and deliver bespoke director training sessions aligned with the UK regulatory environment. Our approach is pragmatic, structured, and rooted in real-world experience.
Our training is delivered by governance specialists and capital markets professionals with first-hand experience advising public company boards. Each programme is customised to address the company’s operational realities, sector-specific risks, and stage of growth.
If your board would benefit from clarity around disclosure obligations, inside information controls, or the UK Listing Rules, First Sentinel can help.
Contact us to discuss a tailored training session or an ongoing board development programme.

UK M&A activity accelerated sharply in the first half of 2026. Total deal value reached £35.4bn, up from £23.1bn in H1 2025 and £15.1bn in H2 2025, with deal volume up 37% year-on-year. For a market that has spent recent periods focused on valuation and liquidity, that is a notable shift in tempo, and one with direct implications for boards, investors and advisers across the UK quoted company landscape.
Foreign bidders accounted for 86% of total deal value, up from 75% in 2025. Not every approach converts into a completed deal, however: around one in six offers made during the period failed to complete, a useful reminder that rising deal activity does not automatically mean rising deal certainty
Valuation remains the clearest driver of interest from overseas buyers. UK companies on the Morningstar index were trading at around 17.2x earnings, against 26.9x in the US. Even with acquisition premiums averaging 40-45% in H1 2026, UK targets can still appear attractively priced relative to comparable US assets.
A few structural factors help explain the discount. UK pension funds have significantly reduced domestic equity allocations over the past decade, a trend that has been mirrored by retail investors and wealth managers. The UK market has also not produced the kind of large, high-profile technology listings that have anchored valuations elsewhere. Stamp duty of 0.5% on share purchases, while modest, remains a further friction point for investors weighing UK equities against alternatives.
Taken together, these factors help explain why the valuation gap has proven so persistent, and why it continues to attract strategic and financial buyers to UK-listed businesses.
The picture on AIM illustrates the broader trend most clearly. The market now has 598 companies, its lowest level since December 2001, down from a peak of around 1,700 in 2007. New admissions remain limited: AIM saw just 11 IPOs in 2024, 14 in 2025, and only 3 in the first half of 2026.
At the same time, takeover activity continues to remove companies from the market. Since 2023, 154 bids for companies worth more than £100m have removed £165bn of market capitalisation, while new listings have added only £6bn over the same period, roughly £27 leaving the market for every £1 arriving.
This creates a self-reinforcing dynamic. As companies leave, liquidity in the remaining names can come under pressure, which in turn can widen valuation discounts and make the remaining companies more visible to prospective bidders. It is a trend worth watching closely, both for what it means for individual companies and for the broader health of the small and mid-cap ecosystem.
Buyer composition in H1 2026 was reasonably balanced between financial and strategic capital. Private equity accounted for 43% of deals, driven primarily by large US firms, while trade and strategic buyers, weighted more towards Europe, made up 52%.
The contest for Spectris plc was one of the period’s more notable examples of competitive tension between bidders. Advent’s initial offer of £37.63 per share was ultimately outbid by KKR, triggering a bidding war for the diversified industrial group, which spans instrumentation, semiconductors and aerospace and defence applications. Situations like this, where multiple credible bidders compete for the same asset, are often a useful signal of where broader buyer appetite is concentrated.
It is easy to focus on the largest, most publicised transactions when reading M&A headlines. The more relevant data point for much of the market is that 70% of UK public M&A deals in 2025 involved companies valued below £500m, and in H1 2026 a majority — 56% — of firm offers targeted companies with market capitalisations below £250m. That places the bulk of current M&A activity firmly within the small and mid-cap space, where relationships, sector knowledge and market visibility tend to matter most.
For boards, the practical implication is a heightened chance of receiving an approach, particularly for companies trading at a persistent discount to peers or with limited liquidity. A discount left unaddressed is now more likely to attract a bid than simply persist quietly. Having a clear, current answer to why the company should remain independent, and the governance and shareholder groundwork to support that answer, matters well before any approach arrives.
For investors, the current environment creates more frequent opportunities for value realisation through takeover premiums, particularly among undervalued small and mid-cap names. It is also worth weighing portfolio holdings against bid vulnerability, low liquidity, a sustained valuation discount, weak share price momentum, as a distinct factor alongside fundamentals. For those holding AIM-heavy portfolios, continued attrition in the index is gradually changing the liquidity and diversification profile of that segment.
The current environment reflects a market where valuation, liquidity and strategic positioning are increasingly interconnected. A persistent valuation discount, a contracting AIM market and continued interest from both private equity and strategic buyers are combining to create a more active period for UK M&A, particularly outside the largest transactions.
For boards and management teams, this is a useful moment to take stock of how the company is perceived by investors and potential counterparties, regardless of whether a transaction is currently under consideration. For advisers and market participants more broadly, it reinforces the value of staying close to market developments, since many of the most relevant conversations begin well before anything becomes public.
This article is general commentary for information purposes only and does not constitute investment advice. If you would like to discuss what current M&A market conditions might mean for your business, First Sentinel’s corporate finance team would welcome the conversation.

Buybacks have become a routine way for companies to return surplus cash, support the share price, or offset dilution from employee share schemes. But a buyback isn’t just “buy some shares back.” It sits at the intersection of company law, market abuse rules, listing obligations and takeover rules, and getting any one of them wrong can be expensive. Here’s the framework as it actually applies today, including the bit most explainers skip: what’s different if you’re on AIM or Aquis rather than the Main Market.
Every buyback of a company incorporated in England and Wales begins with the Companies Act 2006, and there are two routes. Market purchases are made on a recognised exchange, the LSE Main Market, AIM, or Aquis, and are the route almost all public companies use. Off-market purchases are privately negotiated and need a special resolution.
For a market purchase, shareholders grant authority by ordinary resolution, setting the maximum number of shares, a price collar, and an expiry date of no more than five years, though most listed companies simply renew this every year at the AGM. Only fully paid shares can be bought back, and once repurchased they’re either cancelled or held in treasury.
The detail that trips people up: the purchase has to be funded out of distributable reserves or the proceeds of a fresh share issue, and those reserves need to cover the full purchase price, not just the nominal value. Get this wrong and the purchase can be unlawful and void, with directors personally exposed and the selling shareholder potentially on the hook to repay the proceeds.
Once your shares are trading, every buyback purchase is, in principle, a trade in your own shares by someone who might well hold inside information. Without an exemption, that risks being treated as insider dealing or market manipulation under UK MAR.
Article 5 of UK MAR provides a safe harbour, but it’s conditional, and optional, not a blanket permission. To sit inside it, a buyback programme generally needs:
Step outside the safe harbour and none of it applies retroactively: every trade then has to be justified individually against the general market abuse rules. Most issuers and their banks structure programmes specifically to stay inside Article 5 rather than risk that.
Most buyback explainers are written with FTSE 350 companies in mind, and it shows, including in how disclosure obligations get described. It’s worth being precise about what actually carries over to smaller growth companies.
What’s the same: the Companies Act mechanics above apply regardless of which market you’re on. And UK MAR applies too: AIM and Aquis are both UK trading venues within its scope, so the Article 5 safe harbour, and its conditions, are just as relevant whether you’re a Main Market company or a growth company.
What’s different: the UK Listing Rules, including the specific duty to notify a Regulatory Information Service by the end of the 7th daily market session, only apply to companies with shares admitted to the Main Market’s equity shares category. AIM and Aquis companies aren’t “listed” in that technical sense, so that particular rule doesn’t sit on top of your MAR obligations the way it does for a Main Market issuer. Instead, your disclosure duties run through the AIM Rules (or the Aquis equivalent) alongside whatever MAR itself requires if you’re relying on the Article 5 safe harbour.
In practice this usually means less duplicated paperwork than a Main Market company faces, but it’s exactly the kind of detail worth confirming with your NOMAD or corporate adviser before you assume a Main Market explainer applies to you word for word.
The trickiest practical question is usually what happens during the 30-day closed period ahead of half-year and full-year results, when discretionary purchases generally have to stop. There are two ways round it:
Structured buybacks of this kind, often priced against average VWAP over the buyback period, aren’t a niche technique. The FCA’s 2025 multi-firm review found they accounted for around 45% of completed buyback volume, particularly among larger issuers.
A buyback shrinks the total number of shares in issue, which quietly pushes up everyone else’s percentage stake even though nobody’s bought anything. For a shareholder or concert party sitting near the 30% threshold, or already in the 30–50% band, that arithmetic can trigger a mandatory offer obligation under Rule 9 of the Takeover Code. If the numbers are close, it’s worth reviewing concert party positions and talking to the Takeover Panel, and potentially lining up a Rule 9 whitewash, before launching, not after.
On top of that sits an announcement regime with several separate strands: RIS notification (where it applies), the Article 5 disclosures themselves, and DTR 5 notifications wherever voting rights thresholds get crossed.
None of this needs to be worked out once a programme is already trading. Settling it upfront is what actually keeps a buyback simple in practice.
This article is general commentary for information purposes only and isn’t legal or investment advice. Buyback rules turn on your specific market, share class and circumstances, so always check your position with your corporate adviser, NOMAD or legal counsel before acting.
Thinking about a buyback, or want a second opinion on a programme you’re planning? Talk to First Sentinel’s corporate finance team

The UK IPO market in H1 2026 was defined by selective activity, concentrated capital raising and continued focus on market reform. Across the UK public markets, there were 7 IPOs in total, down from 14 in H1 2025 and 21 in H2 2025. Total new listing capital came to £517 million, although one transaction accounted for the majority of that figure.
That does not mean public markets activity stopped. It means the market has become more discriminating. For boards, founders and management teams considering a listing, the question is no longer simply whether capital is available. The more relevant question is: what type of company is attracting interest, on which market, and under what conditions?
The headline numbers tell a clear story. The Main Market, AIM and Aquis all saw lower levels of new issuance in the first half of the year.
On the UK Main Market, there was only one domestic IPO, I4X, alongside Meridian Mining, a Brazilian gold and copper company which raised £25 million. The International Main Market generated most of the capital raised, with two IPOs and £478 million in proceeds, largely driven by the Uzbekistan National Investment Fund transaction.
On AIM, there were three IPOs raising £29.4 million in total. Notably, the H1 cohort did not include tech, AI or life sciences issuers. Instead, mining and minerals remained the dominant sector theme. AIM new listing capital has now declined over consecutive periods, moving from £124 million to £83.2 million and then to £29.4 million.
On Aquis, there was one IPO, Roundhouse, which raised £1.1 million. But that only tells part of the story. The market also saw 71 further-issue transactions, suggesting that while new admissions remain limited, follow-on fundraising continues to play an important role. Repeat issuers including Menel Helium, Stack BTC and Delta Gold each raised capital five times.
It is easy to read lower IPO numbers as a sign of inactivity. That would miss the nuance.
What the first half really showed is a market where capital is concentrating around specific transactions, while broader issuance remains selective. One of the clearest examples was the Uzbekistan National Investment Fund, which raised around $453 million at a $1.46 billion valuation via GDRs on the International Main Market. The deal was reportedly four times oversubscribed and managed by Franklin Templeton.
That transaction matters not only because of its size, but because it highlights where investor appetite may still exist: differentiated stories, significant assets and structures that stand out in a quieter issuance environment. It also raises a wider strategic question for London: whether similar sovereign or state-backed structures from resource-rich jurisdictions could use the UK market in future.
A central question is whether regulatory reform can improve activity in the second half of 2026.
Reforms across the UK Listing Rules, AIM framework and Aquis prospectus / admissions processes are intended to make the markets more workable and more attractive. The open question is whether reform alone is enough to shift behaviour quickly.
In practice, regulation is only one piece of the equation. Companies still need the right equity story, realistic pricing expectations, supportive investors and sufficient liquidity. Even where formal barriers are lowered, issuers and advisers will still need to make a persuasive case for why a public listing is the right route.
That is why the H2 outlook is less about predicting a sudden rebound and more about assessing whether reforms begin to improve confidence, widen the pipeline and support a steadier rhythm of transactions.
Public markets advisers should not view IPO activity in isolation. Public M&A remains an active part of the landscape. There were 30 public M&A transactions involving Main Market and AIM targets, with deal values more than doubling even though the number of deals fell by 22. Asset management consolidation was highlighted as one driver.
That creates a useful strategic reminder for companies and boards: a quieter IPO market does not necessarily mean an absence of corporate activity. In some periods, consolidation, take-privates, secondary fundraising and strategic combinations can become more relevant than primary issuance.
For advisers, this supports a broader message: companies need help navigating the full public markets toolkit, not just the IPO process in isolation.
For companies considering a public market transaction, H1 2026 offers several practical lessons.
First, preparation matters more in a selective market. Investors are likely to be more discerning, and issuers need to be ready with a clear growth story, realistic valuation expectations and a credible use of proceeds.
Second, market choice matters. The right route may differ depending on sector, maturity, capital needs and investor profile. The distinction between Main Market, AIM and Aquis is not just regulatory; it also affects visibility, liquidity, peer group and future fundraising options.
Third, follow-on capital and M&A strategy should sit alongside IPO planning. In a market where new issuance is selective, flexibility matters. Boards should think about whether their objectives are best served by an IPO, a secondary raise, a strategic partnership or corporate activity.
The UK IPO market in H1 2026 was quieter than prior periods, but it still offered useful signals. Activity has not disappeared; it has become more concentrated and more selective. Capital can still be raised, but issuers need stronger positioning and sharper execution.
The second half of the year will be an important test of whether market reform, adviser positioning and issuer readiness can translate into broader momentum. For companies considering a listing, now is a good time to prepare early, assess market fit carefully and stay close to advisers who understand the evolving public markets environment.

The UK’s First Regulated Private Stock Market Explained
The UK public equity market has experienced a sustained structural contraction over the past two decades. The number of listed companies has declined materially during this period, while IPO activity has fallen to multi-year lows. In response, the UK government has prioritised the reinvigoration of the domestic equity capital markets and has introduced a series of reforms aimed at improving the competitiveness of London as a listing venue. These reforms, many of which have been implemented through the FCA’s revised listing regime, include simplifying listing procedures, permitting dual-class share structures, and reducing minimum free float requirements for listed companies.
More recently, alongside the broader public markets reform agenda, policymakers and regulators have introduced a new mechanism designed to expand access to market-based liquidity solutions for private companies. The initiative, known as PISCES (Private Intermittent Securities and Capital Exchange System), enables private companies to facilitate the trading of existing shares through intermittent trading windows in a regulated environment.
In our view, this could become an important stepping stone for companies seeking to test investor appetite, provide liquidity to shareholders, and familiarise themselves with the disciplines of public markets before fully committing to the public equity markets.
PISCES was established under the Financial Services and Markets Act 2023 and implemented through a regulatory sandbox framework developed by HM Treasury and the FCA. The FCA published its final PISCES rules in June 2025, with the regulatory framework becoming operational shortly thereafter. The London Stock Exchange (“LSE”), the first operator authorised by the FCA to operate a PISCES platform, has stated that “the PISCES market model has been designed to make bilateral private share transactions more efficient by using the public market infrastructure without seeking to impose public market-like obligations that would be overly burdensome for private companies to comply with”.
At its core, PISCES is a secondary market: no new shares are issued through the platform, and it cannot be used for primary fundraising, IPOs, or company-led share buybacks. Instead, it provides a regulated venue through which existing shareholders in private companies can sell shares to eligible buyers during defined, intermittent trading windows.
Under the PISCES framework, companies retain significant control over how and when liquidity events occur. Companies admitted to a PISCES platform may determine:
Trading events are time-limited and are expected to take place through periodic auctions or similarly structured mechanisms operated by approved platform providers.
The PISCES ecosystem involves several participants working together to facilitate transactions between buyers and sellers of private company shares within a regulated secondary market environment.
Platform operators provide and manage the regulated trading infrastructure through which transactions are conducted. These operators organise trading events, manage auction or matching mechanisms, oversee investor access, and ensure compliance with applicable market rules and FCA requirements.
Potential operators may include:
Specialist corporate advisers and financial intermediaries are expected to play a central role in the PISCES ecosystem by facilitating transactions between companies, existing shareholders, and prospective investors.
Their role may include:
Depending on the structure adopted by each platform operator, intermediaries may include:
The extent to which intermediaries are required may vary depending on the specific operator model and the regulatory status or sophistication of participating investors. LSE, for example, requires that investors participate through a specific registered intermediary called Register Auction Agent, a role that can be played by regulated advisers or broker platforms. Under the LSE rules, the register auction agent is responsible for (i) investor categorisation under the PISCES Regulations; (ii) granting investor access to the PSM Disclosure Portal, and (iii) placing orders in Auctions.
Existing shareholders may use PISCES trading windows to achieve partial liquidity, while approved investors gain access to private company investment opportunities within a more structured and regulated environment. It is important to note that PISCES trading is not available to retail investors.
Depending on the rules of the relevant platform operator, investors may participate either directly or through authorised financial intermediaries.
PISCES operates under a five-year sandbox (running to June 2030), during which the FCA will test and refine the regulatory framework. The Treasury is required to report to Parliament on whether PISCES is functioning as intended by June 2030, at which point the regime may be transferred into permanent legislation.
Key features of the regulatory framework include:
PISCES is potentially transformative for a range of market participants, though its appeal will vary significantly depending on the circumstances of each company and investor.
Companies that are growing strongly but are not yet ready — or willing — to pursue a full IPO stand to benefit significantly. PISCES allows them to offer shareholders a liquidity pathway without committing to the ongoing disclosure obligations, regulatory burden, and market scrutiny of a public listing. It can also help companies manage their cap tables more actively, enabling early investors to exit and new strategic investors to enter.
For founders who have taken significant personal financial risk and have substantial illiquid wealth tied up in their company, PISCES offers a way to realise some value at intervals without triggering a full exit. This can be important for personal financial planning and for maintaining focus on the long-term development of the business.
VC funds and angel investors typically operate on defined fund lifecycles, and the inability to achieve timely exits has long been cited as a structural weakness in the UK’s private capital ecosystem. PISCES provides a partial solution — enabling funds to return capital to their own investors through periodic secondary sales, potentially at market-determined prices, without requiring an acquisition or public listing.
Employees who hold shares or vested options in high-growth private companies often face years of waiting before they can realise any value. In sectors where equity compensation is central to talent retention — technology, life sciences, fintech — PISCES could be a meaningful differentiator, allowing companies to offer a credible and regulated liquidity pathway to employees.
For investors seeking diversified exposure to private markets — pension funds, family offices, wealth managers, and institutional investors — PISCES opens a new and regulated route to access high-growth private companies that would previously have been largely inaccessible outside of direct venture capital or private equity investment.
As of June 2026, four operators have received FCA approval to run PISCES platforms. Each has taken a distinct approach, reflecting different target markets and business models.

The LSE was the first approved operator, receiving its approval in August 2025. Its platform targets more established private companies, with a structured broker registration process (Registered Auction Agents) and a centralised disclosure portal. The annual fee of £25,000 covering two auctions reflects its positioning toward larger, more mature businesses. Introductory fee waivers are available to encourage early adoption.
JP Jenkins — an established UK venue for unlisted securities — received its approval in November 2025 and has taken a deliberately more accessible approach. With no minimum financial thresholds and a governance-based eligibility test (two directors, five shareholders, and freely transferable shares), its platform is designed to serve a broader universe of private companies including earlier-stage and venture-backed businesses. Its ‘Sweeper Model’ places an affirmative obligation on directors to proactively disclose all material information at each trading event — a counterbalance to lighter admission criteria.
Asset Match was approved in April 2026. An established specialist in periodic auction-based trading for unlisted companies, it brings an existing track record and investor base into the PISCES framework, offering a familiar model for companies and investors already operating in the unlisted securities space.
Vestd received FCA approval on 29 April 2026, becoming the only PISCES operator to operate without financial intermediaries. Buyers face no platform fees, and investors can work directly with the operator. Vestd’s platform is integrated with its broader equity management offering — covering share schemes, cap table management, and now regulated liquidity events — making it particularly suited to SMEs and growth companies that already use its equity administration services.
After approximately nine months of regulatory preparation and operator approvals, PISCES moved from framework to live market in March 2026, with two landmark transactions taking place within days of each other.
UK-based board games developer QPlay became the first private company to have its shares traded under the PISCES regime. The five-day trading window on JP Jenkins’ platform — with Peel Hunt and Winterflood Securities acting as intermediary brokers — illustrated the intermittent trading model at the heart of PISCES. The transaction demonstrated how the framework can provide existing shareholders and early-stage investors with a structured secondary liquidity mechanism without requiring the company to pursue a traditional IPO or corporate sale process
The LSE hosted its inaugural PISCES transaction one week later through a more structurally sophisticated model. Rather than admitting the underlying company directly onto the platform, the transaction utilised a TPEIC (Tradable Private Equity Investment Company) — a Luxembourg securitisation vehicle holding exposure to Oxford Science Enterprises (OSE), the £1.3 billion venture capital firm commercialising research from the University of Oxford.
The structure allowed investors to obtain tradable exposure to OSE while the underlying company itself remained outside the platform and continued operating as a private company. This introduced a significant structural innovation within the PISCES framework by enabling exchange-based secondary liquidity through a securitisation wrapper rather than through direct participation by the issuer itself.
PISCES represents one of the most significant structural developments in UK private markets in a generation. For private companies, shareholders, and investors, it introduces a genuinely new set of strategic options — from shareholder liquidity and employee participation to broader capital markets readiness.
As an FCA-regulated corporate finance firm, we are well-positioned to support clients in evaluating and navigating the PISCES framework, including transaction execution, shareholder liquidity strategies, regulatory advice, and engagement with market operators and intermediaries.
Our advisory capabilities include:
PISCES is still in its earliest stages, and the rules, operators, and market conventions are continuing to evolve. Now is precisely the right time for private companies, shareholders, and investors to take stock of what this market offers and to begin building the relationships and preparations that will position them to benefit as the market matures.
If you would like to discuss PISCES and what it might mean for your business or investment portfolio, we would welcome the opportunity to speak with you.
This article is provided for general information purposes only and does not constitute financial, legal, or regulatory advice. The PISCES framework is subject to ongoing regulatory development and the information contained herein reflects publicly available information as at June 2026. Recipients should seek independent professional advice before making any decisions in connection with the matters described in this article.

First Sentinel’s Head of Corporate Finance, Gabrielle Cordeiro, attended the QCA’s breakfast launch of their new report this morning. Here are the key takeaways.
The Quoted Companies Alliance (QCA) published a new report today: Banking on Britain: How to Catalyse More Investment for UK Growth Companies. Launched at a breakfast event this morning, it makes a well-evidenced and genuinely optimistic case for the potential sitting within the UK’s smaller quoted companies.
AIM and Aquis-listed companies are a vital, and often underappreciated, part of the UK economy. AIM companies alone contribute £68bn in Gross Value Added and support over 778,000 jobs nationally. They operate across all eight of the government’s Industrial Strategy priority sectors and are 50% more productive than the national average.
The growth story is striking too. Companies quoted on AIM have historically delivered 12.7% employee growth and 40.8% operating profit growth following IPO. In terms of long-term returns, £1 invested in the smaller companies index in 1955 would be worth £29,638 today, compared to £1,900 for large caps. Their forecast earnings growth is within three percentage points of Nasdaq, yet they trade at less than a third of the valuation multiple.
The potential is clearly there. The question is how to unlock it.
There is a structural gap in the UK’s growth finance ecosystem that the report identifies clearly. Smaller quoted companies often find themselves in a difficult middle ground: they have outgrown EIS and VCT eligibility but remain too small to attract meaningful institutional investment. Around 365 AIM companies currently sit in that gap.
The QCA frames this not as a crisis but as a solvable problem, and one with a clear solution.
The British Business Bank has done excellent work supporting private companies at every stage, from angel syndicates and university spinouts through to venture capital funds. The QCA’s proposal is a natural extension of that mission: allocate £1bn to invest in the UK’s quoted company sector, with a particular focus on companies valued below £100mn.
At less than 4% of the Bank’s existing £25.6bn financial capacity, this is a targeted and proportionate ask. The QCA estimates it could catalyse at least a further £1bn of private investment through crowding-in effects, with the potential for that figure to grow over time as sentiment improves and liquidity increases.
The recommended approach is an indirect model, channelling funding through established smaller-cap fund managers. This mirrors the Bank’s existing British Patient Capital programme and would allow the positive effects to be felt quickly and broadly across the market.
The report draws on a useful international example. In February 2025, Singapore’s Monetary Authority launched a comparable equity market development programme. Within a year, trading volumes on the Singapore Stock Exchange were up 30%, IPOs rose 150% year-on-year, and the programme is estimated to have crowded in enough third-party capital to more than double its original size.
The UK has the companies, the markets and the infrastructure to achieve something similar. What’s needed is a clear institutional signal of confidence to get things moving.
The timing feels right. Recent investor sentiment data shows that 77% of global and pan-European investors who plan to adjust their portfolios intend to increase their UK equity exposure, with 71% expressing appetite to participate in UK IPOs over the next 12 months.
A commitment from the British Business Bank would add real institutional weight to that trend and give other investors further confidence to back this asset class.
Banking on Britain is a timely and well-constructed piece of research. It reframes the conversation around UK smaller quoted companies, not as a problem to be managed but as an opportunity to be seized. The companies are there, the growth prospects are real, and the mechanism to unlock investment is clearly laid out.
We will be watching this proposal closely and hope to see it gain traction with policymakers and the British Business Bank in the months ahead.
Read the full QCA report: Banking on Britain


